Stem cell team aims for spare heart parts in five years

HONG KONG Thu Aug 18, 2011 2:39am EDT

Related Topics

HONG KONG (Reuters) - Stem cell researchers in Hong Kong and the United States are trying to grow spare parts for the human heart that may be ready for tests on people within five years, they said on Thursday.

Scientists have already made basic heart muscle from stem cells, but the Hong Kong-led team wants to refine it so it can replace any part damaged in heart attacks, and to recreate the natural pacemaker, where the heartbeat originates.

"When you get a heart attack, there is a small time window for a cure when the damage is still small. You can cure with a patch, a small tissue, so you won't progress to late stage heart failure," said team leader Ronald Li, director of the University of Hong Kong's Stem Cell & Regenerative Medicine Consortium.

"We have the muscle strip now, but we want it to mimic what we see in the native heart better, (and) that requires engineering," Li told Reuters in an interview.

An organ or section of tissue grown from a person's stem cells can, in general, be surgically implanted only in that same person.

"There are many different types of heart cells. If cells that are responsible for electricity aren't going right, you get arrhythmias or heart rhythm disturbances. There are heart muscle cells that do mechanical heart pumping that work all the time."

The team will use approved human embryonic stem cell lines to build these human heart muscle strips, as well as the native pacemaker for people with arrhythmia, or irregular heart beat.

The team plans first to transplant these muscle strips and pacemakers into pigs, and, if successful, to move to human clinical trials where they will transplant parts of the heart that are grown using the patients' own stem cells in about five years.

"The question is whether we can put it in the heart to integrate with the recipient organ. Even if it becomes integrated, will it last?" Li said.

He added that the team chose to use pigs because porcine hearts were anatomically and functionally more similar to human hearts.

"I am hoping that at the end of the five years, we will have a number of blueprints for designing different prototypes that can be tested," he said.

Stem cells are the body's source of all cells and tissues. They can generate all the cell types of the organ from which they originate. Because of their ability to generate different types of cells, to multiply and self-renew, scientists hope to harness stem cells to treat a variety of diseases and disorders, including cancer, diabetes and injuries.

As well as the Hong Kong experts, the team will include scientists from the Harvard Stem Cell Institute, National Institutes of Health (NIH) and the Mount Sinai School of Medicine in the United States.

(Editing by Daniel Magnowski)

FILED UNDER:
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
I have had a stem cell transplant, which saved my life eleven plus yeas ago, so I follow this field of research with great interest. I expect that there will be success in three years, not five years as, with all due respect, these researchers opine. One arena of research that is neglected in North America is the preservation of ovarian and testicular tissue before cancer treatment, then their replanting after cancer treatment, thus restoring fertility and sexual health. It has been proven in Italy and in Greece, and some work — highly successful — was done in the UK. It is beyond logical comprehension as to why this particular sector is neglected by health researchers and other health professionals..!! It is NOT a small sector. Worldwide millions of cancer survivors are affected. Of course, there is no money to be made by the giant pharmaceutical corporations in this particular line of research and preventative therapy. Perhaps a major Foundation could decide to fund this line of medical research.

C> ALEXANDER BROWN

Aug 19, 2011 10:22am EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.